Pharma Mar, S.A.
PHMMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,373,116 | $749,140 | $1,169,700 | $993,172 |
| - Cash | $63,239 | $60,024 | $149,813 | $113,348 |
| + Debt | $51,075 | $43,669 | $42,630 | $49,333 |
| Enterprise Value | $1,360,952 | $732,785 | $1,062,517 | $929,157 |
| Revenue | $174,855 | $158,153 | $196,343 | $229,831 |
| % Growth | 10.6% | -19.5% | -14.6% | – |
| Gross Profit | $166,672 | $148,540 | $182,704 | $213,394 |
| % Margin | 95.3% | 93.9% | 93.1% | 92.8% |
| EBITDA | $21,227 | $4,549 | $52,066 | $104,085 |
| % Margin | 12.1% | 2.9% | 26.5% | 45.3% |
| Net Income | $26,125 | $1,137 | $49,356 | $92,859 |
| % Margin | 14.9% | 0.7% | 25.1% | 40.4% |
| EPS Diluted | 1.49 | 0.064 | 2.73 | 5.13 |
| % Growth | 2,246.5% | -97.7% | -46.8% | – |
| Operating Cash Flow | $6,027 | -$13,446 | $38,321 | $25,677 |
| Capital Expenditures | -$15,510 | -$15,956 | -$8,852 | -$7,803 |
| Free Cash Flow | -$9,483 | -$29,402 | $29,469 | $17,874 |